NetraMark Holdings Inc. (TSX:AIAI)
0.4900
-0.0600 (-10.91%)
Nov 19, 2026, 4:00 PM EST
NetraMark Holdings Earnings Call Transcripts
Fiscal Year 2026
-
NetraAI leverages proprietary AI to identify subgroups in clinical trial data, improving trial design and success rates, especially in CNS and oncology. The technology is validated by FDA engagement, peer-reviewed publications, and major institutional collaborations, targeting a CAD 10 billion market with high margins and a dual commercialization strategy.